News
Discover why some biotechs fail but survive with cash on hand, and how players like Concentra are trying to unlock trapped ...
Learn about July 2025’s top biotech deals, featuring major collaborations in small molecules, antibodies, and drug delivery.
New narcolepsy treatments are being tested in the clinic, and recently, some of them have made promising strides. How far ...
This past year has seen various developments in the field of oncolytic virus therapies - in fundraising and in the clinic.
Abivax, MapLight Therapeutics, Everest Medicines, and Soleno Therapeutics bagged the biggest biotech funding rounds overall ...
Stay updated on biotech layoffs in 2025! Each week, we track and analyze industry layoffs, their causes, and their impact.
Discover how Genome Valley is emerging as an essential partner in global biopharma and how it is now venturing into cell and gene therapy.
Five acquisitions in 2025—including Cargo and Allakos—have put Concentra Biosciences in the spotlight. Learn what’s behind the strategy.
Meet 12 biotech companies with promising genetic disease therapies that successfully closed funding rounds recently.
Learn how Deep Science Ventures’ zero-data approach tackles biotech’s early funding challenges to speed innovation and reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results